These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 35753086)

  • 1. Is prostatic adenocarcinoma in a relationship with Human Papilloma Virus in Isfahan -Iran.
    Mokhtari M; Taghizadeh F; Hani M
    J Res Med Sci; 2013 Aug; 18(8):707-10. PubMed ID: 24379849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives.
    Nachira D; Congedo MT; D'Argento E; Meacci E; Evangelista J; Sassorossi C; Calabrese G; Nocera A; Kuzmych K; Santangelo R; Rindi G; Margaritora S
    Life (Basel); 2024 Jan; 14(1):. PubMed ID: 38255725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial infections as potential risk factors for lung cancer: Investigating the role of human papillomavirus and chlamydia pneumoniae.
    Drokow EK; Effah CY; Agboyibor C; Budu JT; Arboh F; Kyei-Baffour PA; Xiao Y; Zhang F; Wu IX
    AIMS Public Health; 2023; 10(3):627-646. PubMed ID: 37842273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
    Rajendra S; Sharma P
    Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.
    Rojas L; Mayorga D; Ruiz-Patiño A; Rodríguez J; Cardona AF; Archila P; Avila J; Bravo M; Ricaurte L; Sotelo C; Arrieta O; Zatarain-Barrón ZL; Carranza H; Otero J; Vargas C; Barrón F; Corrales L; Martín C; Recondo G; Pino LE; Bermudez MA; Gamez T; Ordoñez-Reyes C; García-Robledo JE; de Lima VC; Freitas H; Santoyo N; Malapelle U; Russo A; Rolfo C; Rosell R;
    ESMO Open; 2022 Aug; 7(4):100500. PubMed ID: 35753086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection.
    Rajendra S; Xuan W; Merrett N; Sharma P; Sharma P; Pavey D; Yang T; Santos LD; Sharaiha O; Pande G; Cosman P; Wu X; Wang B
    JAMA Netw Open; 2018 Aug; 1(4):e181054. PubMed ID: 30646096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus infections as a marker to predict overall survival in lung adenocarcinoma.
    Wang JL; Fang CL; Wang M; Yu MC; Bai KJ; Lu PC; Liu HE
    Int J Cancer; 2014 Jan; 134(1):65-71. PubMed ID: 23797776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.
    Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Sun X
    Oncotarget; 2017 May; 8(21):34507-34515. PubMed ID: 28427144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human telomerase reverse transcriptase regulates vascular endothelial growth factor expression via human papillomavirus oncogene E7 in HPV-18-positive cervical cancer cells.
    Li F; Cui J
    Med Oncol; 2015 Jul; 32(7):199. PubMed ID: 26067630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
    Bruni D; Angell HK; Galon J
    Nat Rev Cancer; 2020 Nov; 20(11):662-680. PubMed ID: 32753728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscore Predicts Survival in Early-Stage Lung Adenocarcinoma Patients.
    Zhao Z; Zhao D; Xia J; Wang Y; Wang B
    Front Oncol; 2020; 10():691. PubMed ID: 32457841
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung cancer in never smokers: The role of different risk factors other than tobacco smoking.
    Corrales L; Rosell R; Cardona AF; Martín C; Zatarain-Barrón ZL; Arrieta O
    Crit Rev Oncol Hematol; 2020 Apr; 148():102895. PubMed ID: 32062313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
    Burtness B; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Basté N; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Wan Ishak WZ; Hong RL; González Mendoza R; Roy A; Zhang Y; Gumuscu B; Cheng JD; Jin F; Rischin D;
    Lancet; 2019 Nov; 394(10212):1915-1928. PubMed ID: 31679945
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.